Skip to main content
Erschienen in:

21.03.2020 | Original Article

Utilization of robotics for retroperitoneal lymph-node dissection in pediatric and non-pediatric hospitals

verfasst von: Christopher T. Brown, Yuri V. Sebastião, Anja Zann, Daryl J. McLeod, Daniel DaJusta

Erschienen in: Journal of Robotic Surgery | Ausgabe 6/2020

Einloggen, um Zugang zu erhalten

Abstract

The objective of this study is to determine recent trends in use of robotics and laparoscopy for pediatric retroperitoneal lymph-node dissection (RPLND) in pediatric and non-pediatric hospitals. We conducted a retrospective cohort study using data from 29 hospitals in the Pediatric Health Information System (PHIS), and data from 14 states in the State Inpatient Databases (SID), between 2008 and 2014. The study population was comprised of patients aged ≥ 10 years undergoing RPLND, with an inpatient diagnosis of testicular or paratesticular cancer, based on international classification of disease (ICD) codes. Robotic approach was identified by the presence of an ICD procedure code modifier. During the study period, a total of 90 RPLNDs were performed in pediatric hospitals (median patient age 16 years). Of these, 4 (4.4%) were performed robotically. A total of 3120 RPLNDs were performed in non-pediatric hospitals (median patient age: 32 years). Among these, 269 (8.6%) were performed robotically, with an increasing trend in the use of robotic RPLND (adjusted annual increase in probability of undergoing robotic vs. open procedure: 16%; 95% CI 8–24). Undergoing robotic RPLND was associated with a reduction in postoperative length of stay of 3.5 days (95% CI 2.9, 4.1). Open surgical approaches comprise the vast majority of RPLNDs performed at pediatric hospitals. This is in contrast with trends in non-pediatric hospitals where robotic RPLND is being increasingly utilized. Future research is necessary to investigate this discrepancy in adopting minimally invasive techniques for RPLND in pediatric centers.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Hulbert JC, Fraley EE (1992) Laparoscopic retroperitoneal lymphadenectomy: new approach to pathologic staging of clinical stage I germ cell tumors of the testis. J Endourol 6:123–125CrossRef Hulbert JC, Fraley EE (1992) Laparoscopic retroperitoneal lymphadenectomy: new approach to pathologic staging of clinical stage I germ cell tumors of the testis. J Endourol 6:123–125CrossRef
3.
Zurück zum Zitat Rukstalis DB, Chodak GW (1992) Laparoscopic retroperitoneal lymph node dissection in a patient with stage I testicular carcinoma. J Urol 148:1907–1909CrossRef Rukstalis DB, Chodak GW (1992) Laparoscopic retroperitoneal lymph node dissection in a patient with stage I testicular carcinoma. J Urol 148:1907–1909CrossRef
4.
Zurück zum Zitat Davol P, Sumfest J, Rukstalis D (2006) Robotic-assisted laparoscopic retroperitoneal lymph node dissection. Urology 67:199.e7–199.e8CrossRef Davol P, Sumfest J, Rukstalis D (2006) Robotic-assisted laparoscopic retroperitoneal lymph node dissection. Urology 67:199.e7–199.e8CrossRef
5.
Zurück zum Zitat Dogra PN, Singh P, Saini AK et al (2013) Robot assisted laparoscopic retroperitoneal lymph node dissection in testicular tumor. Urol Ann 5:223–226CrossRef Dogra PN, Singh P, Saini AK et al (2013) Robot assisted laparoscopic retroperitoneal lymph node dissection in testicular tumor. Urol Ann 5:223–226CrossRef
6.
Zurück zum Zitat Cheney SM, Andrews PE, Leibovich BC, Castle EP (2015) Robot-assisted retroperitoneal lymph node dissection: technique and initial case series of 18 patients. BJU Int 115:114–120CrossRef Cheney SM, Andrews PE, Leibovich BC, Castle EP (2015) Robot-assisted retroperitoneal lymph node dissection: technique and initial case series of 18 patients. BJU Int 115:114–120CrossRef
9.
Zurück zum Zitat Baniel J, Foster RS, Rowland RG, Bihrle R, Donohue JP (1994) Complications of primary retroperitoneal lymph node dissection. J Urol 152:424–427CrossRef Baniel J, Foster RS, Rowland RG, Bihrle R, Donohue JP (1994) Complications of primary retroperitoneal lymph node dissection. J Urol 152:424–427CrossRef
10.
Zurück zum Zitat Baniel J, Sella A (1999) Complications of retroperitoneal lymph node dissection in testicular cancer: primary and post-chemotherapy. Semin Surg Oncol 17:263–267CrossRef Baniel J, Sella A (1999) Complications of retroperitoneal lymph node dissection in testicular cancer: primary and post-chemotherapy. Semin Surg Oncol 17:263–267CrossRef
11.
Zurück zum Zitat Hugen CM, Hu B, Jeldres C et al (2016) Utilization of retroperitoneal lymph node dissection for testicular cancer in the United States: results from the National Cancer Database (1998–2011). Urol Oncol 34:487.e7–487.e11CrossRef Hugen CM, Hu B, Jeldres C et al (2016) Utilization of retroperitoneal lymph node dissection for testicular cancer in the United States: results from the National Cancer Database (1998–2011). Urol Oncol 34:487.e7–487.e11CrossRef
12.
Zurück zum Zitat Rassweiler JJ, Scheitlin W, Heidenreich A et al (2008) Laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective. Eur Urol 54:1004–1019CrossRef Rassweiler JJ, Scheitlin W, Heidenreich A et al (2008) Laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective. Eur Urol 54:1004–1019CrossRef
13.
Zurück zum Zitat Nielsen ME, Lima G, Schaeffer EM et al (2007) Oncologic efficacy of laparoscopic RPLND in treatment of clinical stage I nonseminomatous germ cell testicular cancer. Urology 70:1168–1172CrossRef Nielsen ME, Lima G, Schaeffer EM et al (2007) Oncologic efficacy of laparoscopic RPLND in treatment of clinical stage I nonseminomatous germ cell testicular cancer. Urology 70:1168–1172CrossRef
14.
Zurück zum Zitat Tomaszewski JJ, Sweeney DD, Kavoussi LR, Ost MC (2010) Laparoscopic retroperitoneal lymph node dissection for high-risk pediatric patients with paratesticular rhabdomyosarcoma. J Endourol 24:31–34CrossRef Tomaszewski JJ, Sweeney DD, Kavoussi LR, Ost MC (2010) Laparoscopic retroperitoneal lymph node dissection for high-risk pediatric patients with paratesticular rhabdomyosarcoma. J Endourol 24:31–34CrossRef
15.
Zurück zum Zitat Schwen ZR, Gupta M, Pierorazio PM (2018) A review of outcomes and technique for the robotic-assisted laparoscopic retroperitoneal lymph node dissection for testicular cancer. Adv Urol 2018:1–7CrossRef Schwen ZR, Gupta M, Pierorazio PM (2018) A review of outcomes and technique for the robotic-assisted laparoscopic retroperitoneal lymph node dissection for testicular cancer. Adv Urol 2018:1–7CrossRef
16.
Zurück zum Zitat Stepanian S, Patel M, Porter J (2016) Robot-assisted laparoscopic retroperitoneal lymph node dissection for testicular cancer: evolution of the technique. Eur Urol 70:661–667CrossRef Stepanian S, Patel M, Porter J (2016) Robot-assisted laparoscopic retroperitoneal lymph node dissection for testicular cancer: evolution of the technique. Eur Urol 70:661–667CrossRef
17.
Zurück zum Zitat Cost NG, DaJusta DG, Granberg CF et al (2012) Robot-assisted laparoscopic retroperitoneal lymph node dissection in an adolescent population. J Endourol 26:635–640CrossRef Cost NG, DaJusta DG, Granberg CF et al (2012) Robot-assisted laparoscopic retroperitoneal lymph node dissection in an adolescent population. J Endourol 26:635–640CrossRef
18.
Zurück zum Zitat Glaser AP, Bowen DK, Lindgren BW, Meeks JJ (2017) Robot-assisted retroperitoneal lymph node dissection (RA-RPLND) in the adolescent population. J Pediatr Urol 13:223–224PubMed Glaser AP, Bowen DK, Lindgren BW, Meeks JJ (2017) Robot-assisted retroperitoneal lymph node dissection (RA-RPLND) in the adolescent population. J Pediatr Urol 13:223–224PubMed
Metadaten
Titel
Utilization of robotics for retroperitoneal lymph-node dissection in pediatric and non-pediatric hospitals
verfasst von
Christopher T. Brown
Yuri V. Sebastião
Anja Zann
Daryl J. McLeod
Daniel DaJusta
Publikationsdatum
21.03.2020
Verlag
Springer London
Erschienen in
Journal of Robotic Surgery / Ausgabe 6/2020
Print ISSN: 1863-2483
Elektronische ISSN: 1863-2491
DOI
https://doi.org/10.1007/s11701-020-01066-7

Neu im Fachgebiet Chirurgie

Akute Cholezystitis bei multimorbiden Älteren: Operation nicht sofort ausschließen!

Bei älteren, multimorbiden Menschen mit akuter Cholezystitis wird eine Operation häufig nicht erwogen. Eine Studie aus Philadelphia zeigt nun jedoch, dass auch diese Patientinnen und Patienten von einer chirurgischen Therapie profitieren können.

Was geschehen muss, damit Prähabilitation in die Leitlinien kommt

Eine Prähabilitation vor einem viszeralchirurgischen Eingriff ist Experten zufolge äußerst sinnvoll, dennoch wird sie in Leitlinien derzeit nicht empfohlen. Beim DCK erklärte Prof. Tim Vilz aus Bonn, woran das liegt und was benötigt wird, um die Situation zu ändern.

Thoracic-Outlet-Syndrom nur in Ausnahmefällen operieren!

Das Thoracic-Outlet-Syndrom erfordert nur in ganz bestimmten Fällen ein operatives Vorgehen. Beim DCK wurde vor schwerwiegenden Komplikationen des anspruchsvollen Eingriffs gewarnt.

Statine: Was der G-BA-Beschluss für Praxen bedeutet

Nach dem G-BA-Beschluss zur erweiterten Verordnungsfähigkeit von Lipidsenkern rechnet die DEGAM mit 200 bis 300 neuen Dauerpatienten pro Praxis. Im Interview erläutert Präsidiumsmitglied Erika Baum, wie Hausärztinnen und Hausärzte am besten vorgehen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.